The collaboration grants Jazz Pharmaceuticals exclusive worldwide rights to develop and commercialise antibodies from the partnership. Credit: Tada Images / Shutterstock.com. · Pharmaceutical ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Jazz Pharmaceuticals is prepping its first solid tumor cancer treatment for launch in early July, focusing on physician awareness and education. That's in part because Zepzelca is the first drug ...
Jazz Pharmaceuticals JAZZ announced that it has initiated enrollment in a phase II basket study — EMERGE-201 — that will evaluate its new cancer drug, Zepzelca (lurbinectedin), as monotherapy for ...
Zanidatamab data demonstrate clinical potential of novel bispecific antibody in HER2-targeted biliary tract and gastric cancers Additional presentations, including a lurbinectedin oral presentation in ...
Jazz Pharmaceuticals JAZZ announced a preclinical research collaboration deal with AbCellera Biologics ABCL to discover and develop next-generation T-cell-engaging (TCE) multispecific antibodies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results